A STUDY TO EVALUATE CORRECTED QT INTERVAL AND DRUG-DRUG INTERACTION OF TRASTUZUMAB ON CARBOPLATIN IN THE PRESENCE OF DOCETAXEL IN PATIENTS WITH HER2-POSITIVE METASTATIC OR LOCALLY ADVANCED INOPERABLE CANCER: